Cheng Fan

3.1k citations
175 papers · 2.0k indexed · h-index 21

Impact in

Papers in

    • Chronic Kidney Disease and Diabetes 15
    • Cancer-related molecular mechanisms research 18
    • MicroRNA in disease regulation 12

Cheng Fan

154 papers receiving 1.9k citations

Peers

Cheng Fan
Comparison fields: 5 of 130
  • Cancer Research 457
  • Nephrology 167
  • Molecular Biology 921
  • Pulmonary and Respiratory Medicine 436
  • Oncology 274
Replace Ming Xu with:
Ming Xu China
Bo Peng China
Jun Shi China
Benkang Shi China
Minghui Zhao China
Samy L. Habib United States
Jing Xiong China
Cheng Fan relative to Ming Xu China Ming Xu's profile →
Citations per field
00.5×
Ming Xu · 1×
Citations per year

Countries citing papers authored by Cheng Fan

Since Specialization
Citations

This map shows the geographic impact of Cheng Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Fan more than expected).

Fields of papers citing papers by Cheng Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Fan. The network helps show where Cheng Fan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cheng Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheng Fan Line = papers co-authored together Cheng Fan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20251
3 20250
4 20250
5 20251
6 20251
7 20251
8 202416
9 20245
10 202425
11 20241
12 20243
13 20248
14 20243
15 20240
16 20235
17 202313
18 20236
19 202319
20 20181

About Cheng Fan

Cheng Fan is a scholar working on Nephrology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Reproductive Medicine, having authored 175 papers that have together received 2.0k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (30 papers), Cancer-related molecular mechanisms research (18 papers), Bladder and Urothelial Cancer Treatments (16 papers), Chronic Kidney Disease and Diabetes (15 papers), Epigenetics and DNA Methylation (15 papers), MicroRNA in disease regulation (12 papers), Kidney Stones and Urolithiasis Treatments (10 papers) and Circular RNAs in diseases (10 papers). The work is most often cited by research in Cancer Research (457 citations), Nephrology (167 citations), Molecular Biology (921 citations), Pulmonary and Respiratory Medicine (436 citations) and Oncology (274 citations). Cheng Fan has collaborated with scholars based in China, United States and France. Frequent co-authors include Weimin Yu, Jinzhuo Ning, Yuan Ruan, Ting Rao, Xiangjun Zhou, Yuqi Xia, Run Yuan, Shaoming Zhu, Haoyong Li and Chen Wu. Their work appears in journals such as Journal of Cellular and Molecular Medicine, International Immunopharmacology, Frontiers in Oncology, Scientific Reports and Journal of Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026